Cannabinoid and adenosine A 2A receptor crosstalk regulates postnatal and adult hippocampal neurogenesis
British Journal of Pharmacology · 2026-09 · 183 (18) · 5440-5457
DOI: 10.1111/bph.70466 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Pharmacology, online erschienen am 22.06.2026. Verfasst von Rui S Rodrigues und 8 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Farmacologia e Neurociências, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal. Hauptthemen laut MEDLINE: Neurogenesis, Hippocampus, Receptor, Adenosine A2A, Receptor, Cannabinoid, CB1. Die Arbeit nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Project LISBOA2030-FEDER-00723600, co-funded by the Lisboa 2030 Program, Portugal 2030 and the European Union (ERDF), and with the support of National Funds th…, FCT Fellowships from Fundação para a Ciência e Tecnologia, Ministerio de Ciencia, Innovación y Universidades-Agencia Estatal de Investigación.
Abstract (Originalsprache)
Background and purpose Adult neurogenesis is a tightly regulated process affected by both cannabinoid receptors (CB 1 and CB 2 ) and adenosine 2A (A 2A ) receptors, both of which modulate neural progenitor cell activity. While emerging evidence suggests an interaction between these neuromodulatory systems, the extent and mechanism of their interplay in regulating neurogenesis remain unclear. Experimental approach Using a combination of in vivo and in vitro approaches together with pharmacological and receptor/binding assays, we investigated the crosstalk between A 2A and CB receptors in regulating hippocampal neurogenesis. Key results In vivo administration of WIN55212‐2, a non‐selective cannabinoid receptor agonist, increased hippocampal cell proliferation and immature neuron formation, an effect abolished by istradefylline, a selective A 2A receptor antagonist. In vitro , activation of CB 2 or A 2A receptors promoted self‐renewing divisions of hippocampal‐derived neural progenitor cells. A 2A receptor antagonism impaired CB 2 receptor‐mediated effects, whereas CB 1 /CB 2 antagonism blocked A 2A ‐mediated effects. Co‐activation of CB 1 or CB 2 receptors with A 2A receptors promoted a significant increase in cell proliferation. Notably, the proneurogenic effects mediated by CB 1 or CB 2 receptor agonists were blocked by A 2A receptor antagonism, while A 2A receptor‐mediated actions on neuronal differentiation were blocked by CB 1 or CB 2 receptor antagonists. Finally, receptor‐binding assays showed that A 2A and CB 1 receptors form heteromers in the mouse hippocampus, suggesting that their functional interaction may involve direct receptor‐receptor crosstalk. Conclusions and implications Taken together, these findings suggest a crosstalk between the adenosinergic and cannabinergic systems responsible for regulating hippocampal progenitor dynamics. The identification of CB 1 –A 2A receptor heteromerization provides new insights into the molecular basis of neurogenic modulation and highlights a promising avenue for the development of novel proneurogenic therapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Instituto de Farmacologia e Neurociências, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.
- Univ. Bordeaux, INSERM, Neurocentre Magendie, U1215, Bordeaux, France.
- Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.
- Pharmacology Unit, Department of Pathology and Experimental Therapeutics, Faculty of Medicine and Health Sciences, Institute of Neurosciences, University of Barcelona, Barcelona, Spain.
- Neuropharmacology & Pain Group, Neuroscience Program, Institut d'Investigación Biomèdica de Bellvitge, IDIBELL, Barcelona, Spain.
- GIMM - Gulbenkian Institute of Molecular Medicine, Lisbon, Portugal.
ORCID-Profile: Rui S Rodrigues, Adam Armada-Moreira, Laura Gómez-Acero, Filipa F Ribeiro, Francisco M Mouro, Ana M Sebastião, Francisco Ciruela, Ester Aso, Sara Xapelli
Förderung
- Project LISBOA2030-FEDER-00723600, co-funded by the Lisboa 2030 Program, Portugal 2030 and the European Union (ERDF), and with the support of National Funds th…
- FCT Fellowships from Fundação para a Ciência e Tecnologia
- Ministerio de Ciencia, Innovación y Universidades-Agencia Estatal de Investigación
- European Regional Development Fund
Zitieren
APA
Rodrigues, R. S., Armada-Moreira, A., Gómez-Acero, L., Ribeiro, F. F., Mouro, F. M., Sebastião, A. M., Ciruela, F., Aso, E., & Xapelli, S. (2026). Cannabinoid and adenosine A 2A receptor crosstalk regulates postnatal and adult hippocampal neurogenesis. British Journal of Pharmacology, 183(18), 5440-5457. https://doi.org/10.1111/bph.70466
Vancouver
Rodrigues RS, Armada-Moreira A, Gómez-Acero L, Ribeiro FF, Mouro FM, Sebastião AM, et al. Cannabinoid and adenosine A 2A receptor crosstalk regulates postnatal and adult hippocampal neurogenesis. British Journal of Pharmacology. 2026;183(18):5440-5457. doi:10.1111/bph.70466
BibTeX
@article{Rodrigues2026,
author = {Rodrigues, Rui S and Armada-Moreira, Adam and Gómez-Acero, Laura and Ribeiro, Filipa F and Mouro, Francisco M and Sebastião, Ana M and Ciruela, Francisco and Aso, Ester and Xapelli, Sara},
title = {Cannabinoid and adenosine A 2A receptor crosstalk regulates postnatal and adult hippocampal neurogenesis},
journal = {British Journal of Pharmacology},
year = {2026},
volume = {183},
number = {18},
pages = {5440--5457},
doi = {10.1111/bph.70466}
}
EUVIMED